Your browser doesn't support javascript.
loading
Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma.
Borsoi, Carlotta; Leonard, Fransisca; Lee, Yeonju; Zaid, Mohamed; Elganainy, Dalia; Alexander, Jenolyn Francisca; Kai, Megumi; Liu, Yan Ting; Kang, Yaan; Liu, Xuewu; Koay, Eugene J; Ferrari, Mauro; Godin, Biana; Yokoi, Kenji.
Affiliation
  • Borsoi C; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Leonard F; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Lee Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Zaid M; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Elganainy D; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Alexander JF; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Kai M; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Liu YT; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Kang Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Liu X; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA.
  • Koay EJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Ferrari M; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA; Department of Medicine, Weill Cornell Medicine, 1300 York Ave., New York, NY 10065, USA. Electronic address: mferrari@houstonmethodist.org.
  • Godin B; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA. Electronic address: bianagodinv@gmail.com.
  • Yokoi K; Department of Nanomedicine, Houston Methodist Research Institute, 6700 Bertner Ave., Houston, TX 77030, USA. Electronic address: kyokoi@houstonmethodist.org.
Cancer Lett ; 403: 296-304, 2017 09 10.
Article in En | MEDLINE | ID: mdl-28687352
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Drug Carriers / Drug Resistance, Neoplasm / Carcinoma, Pancreatic Ductal / Deoxycytidine / Nanoparticles / Albumin-Bound Paclitaxel / Antimetabolites, Antineoplastic / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Lett Year: 2017 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Drug Carriers / Drug Resistance, Neoplasm / Carcinoma, Pancreatic Ductal / Deoxycytidine / Nanoparticles / Albumin-Bound Paclitaxel / Antimetabolites, Antineoplastic / Antineoplastic Agents, Phytogenic Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cancer Lett Year: 2017 Type: Article Affiliation country: United States